Vericel(us:VCEL)
43.08
-3.45%
Updated on 2025-04-02
Open:44.34
Close:43.08
High:44.97
Low:42.56
Prev Close:44.62
Volume:421300.00
Turnover:18.30M
Turnover Ratio:0.84%
Shares:50.14M
MarketCap:2.16B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 280 | 50553928 | 103.46% | 35 | 93 | 117 |
| 2024-03-31 | 270 | 51372477 | 105.95% | 48 | 83 | 104 |
| 2023-12-31 | 239 | 51777405 | 108.25% | 31 | 60 | 111 |
| 2023-09-30 | 225 | 51348651 | 107.69% | 28 | 77 | 91 |
| 2023-06-30 | 223 | 49958266 | 104.92% | 26 | 77 | 96 |
| 2023-03-31 | 210 | 50267772 | 105.81% | 40 | 67 | 76 |
| 2022-12-31 | 201 | 50365342 | 106.59% | 25 | 54 | 95 |
| 2022-09-30 | 199 | 52215762 | 110.62% | 21 | 72 | 79 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Blackrock Inc. | 8056828 | 16.49% | 87312 | 1.10% |
| 2024-06-30 | Brown Capital Management Llc | 4416684 | 9.04% | -534259 | -10.79% |
| 2024-06-30 | Vanguard Group Inc | 3444682 | 7.05% | 31240 | 0.92% |
| 2024-06-30 | State Street Corp | 2484785 | 5.09% | -729883 | -22.70% |
| 2024-06-30 | Fmr Llc | 2350351 | 4.81% | 241765 | 11.47% |
| 2024-06-30 | Conestoga Capital Advisors, Llc | 2041370 | 4.18% | -289940 | -12.44% |
| 2024-06-30 | Invesco Ltd. | 1799183 | 3.68% | 1282191 | 248.01% |
| 2024-06-30 | Gw&K Investment Management, Llc | 1255762 | 2.57% | 30086 | 2.46% |
| 2024-06-30 | Geode Capital Management, Llc | 1144440 | 2.34% | 80495 | 7.57% |
| 2024-06-30 | New York State Common Retirement Fund | 1093670 | 2.24% | 32309 | 3.04% |
About
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
Address:64 Sidney Street
Website:http://www.vcel.com
Market Movers